C1s is the modular serine protease responsible for cleavage of C4 and C2, the protein substrates of the first component of complement. Its catalytic region (␥-B) comprises two complement control protein (CCP) modules, a short activation peptide (ap), and a serine protease domain (SP). A baculovirus-mediated expression system was used to produce recombinant truncated fragments from this region, deleted either from the first CCP module (CCP 2 -ap-SP) or from both CCP modules (ap-SP). The aglycosylated fragment CCP 2 -ap-SPag was also expressed by using tunicamycin. The fragments were produced at yields of 0.6 -3 mg/liter of culture, isolated, and characterized chemically and then tested functionally by comparison with intact C1s and its proteolytic ␥-B fragment. All recombinant fragments were expressed in a proenzyme form and cleaved by C1 r to generate active enzymes expressing esterolytic activity and reactivity toward C1 inhibitor comparable to those of intact C1 s. Likewise, the activated fragments ␥-B, CCP 2 -ap-SP, and ap-SP retained C1 s ability to cleave C2 in the fluid phase. In contrast, whereas fragment ␥-B cleaved C4 as efficiently as C1 s, the C4-cleaving activity of CCP 2 -ap-SP was greatly reduced (about 70-fold) and that of ap-SP was abolished. It is concluded that C4 cleavage involves substrate recognition sites located in both CCP modules of C1 s, whereas C2 cleavage is affected mainly by the serine protease domain. Evidence is also provided that the carbohydrate moiety linked to the second CCP module of C1 s has no significant effect on catalytic activity.
The first component of complement comprises two homologous, yet distinct modular serine proteases C1r 1 and C1s assembled in the form of a Ca 2ϩ -dependent tetramer C1s-C1r-C1r-C1s. C1r is responsible for intrinsic C1 activation, a twostep process first involving autolytic C1r activation and then C1 r-mediated cleavage of proenzyme C1s. The active enzyme C1 s is a highly specific protease with trypsin-like specificity that mediates limited proteolysis of C4 and C2, the two protein substrates of C1 , thereby triggering activation of the classical pathway of complement in response to infection by various microorganisms (2) (3) (4) (5) . C4 cleavage occurs in the fluid phase and generates fragment C4b, which has the transient ability to bind covalently to the surface of the target. Cleavage of the second substrate C2, in contrast, takes place after prior formation of a C4b-C2 complex and yields C4b-C2a, the protease responsible for cleavage of complement protein C3 (5) . This double proteolytic activity of C1 is controlled by C1 inhibitor, a member of the serine protease inhibitor (serpin) family, which reacts stoichiometrically with both C1 r and C1 s to form covalent protease-inhibitor complexes, resulting in disruption of the C1 s-C1 r-C1 r-C1 s tetramer (2) .
Human C1s is synthesized as a 673-residue single chain zymogen which, upon activation by C1 r, is cleaved between Arg 422 and Ile 423 to yield two disulfide-linked polypeptides, the N-terminal A chain comprising a series of five protein modules and the serine protease B domain (6 -8) . Limited proteolysis of C1 s with plasmin yields a C-terminal fragment ␥-B, comprising two contiguous complement control protein (CCP) modules, a 15-residue intermediary segment homologous to the activation peptide in chymotrypsinogen, and the serine protease domain (9) . The CCP modules (originally known as short consensus repeats) are structural motifs of about 60 residues homologous to those mostly found in various complement regulatory proteins known to interact with components C3b and/or C4b (10) . The C-terminal CCP module of C1s bears a heterogeneous, complex-type N-linked oligosaccharide with both biantennary and triantennary species (11) . Based on chemical cross-linking and three-dimensional homology modeling, it was shown recently that this module closely interacts with the serine protease domain on the side opposite to both the active site and the Arg 422 -Ile 423 bond cleaved upon activation (12) . From a functional point of view, the fact that the proteolytic fragment ␥-B retains a functional active site (9) and studies based on the use of monoclonal antibodies indicating that the ␥ segment may be involved in C4 binding (13, 14) together sug-gest that ␥-B may represent the catalytic region of C1 s. However, no precise information is available yet on the respective role of the serine protease domain and CCP modules in the various aspects of C1 s catalytic activity. The present study provides identification of the domains of C1s involved in its activation by C1 r, proteolytic activity toward C4 and C2, and reactivity toward C1 inhibitor, based on baculovirus-mediated expression of truncated recombinant fragments from the ␥-B region.
EXPERIMENTAL PROCEDURES
Materials-Diisopropylphosphorofluoridate, neuraminidase (type X), and the synthetic substrate N ␣ -benzoyl-L-arginine ethyl ester were from Sigma. Human plasmin was obtained from Chromogenix AB (Mölndal, Sweden). Polyclonal anti-C1 s antiserum was raised in rabbits according to standard procedures. Restriction enzymes were from Boehringer Mannheim. Vent R polymerase was from New England Biolabs. The pHC1s46 vector encoding human C1s (6) was kindly provided by Dr. Mario Tosi (Laboratoire d'Immunogénétique, Institut Pasteur, Paris). The pVT-Bac vector was kindly provided by Dr. Thierry Vernet (Institut de Biologie Structurale, Grenoble). Antibiotics and molecular biology reagents were from Appligen Oncor.
Proteins-Proenzyme C1s and activated C1r and C1s were purified from human plasma as described previously (15, 16 ). The C1 s ␥-B fragment was obtained by limited proteolysis with plasmin (17) and purified by ion-exchange chromatography on a Mono Q HR 5/5 column (Pharmacia Biotech Inc.) as described previously (12) . The two glycoforms of the C1 s ␥-B fragment, containing either a biantennary or a triantennary oligosaccharide, were isolated by affinity chromatography on concanavalin A-Sepharose (Pharmacia) as described previously (11) . The desialylated C1 s ␥-B fragment was obtained by treatment with neuraminidase (10 units/mg protein) for 5 h at 25°C. Complement proteins C2, C4, and C1 inhibitor were isolated from human plasma by means of published procedures (18 -20) . For the determination of protein concentrations the following absorption coefficients (A (1%, 1 cm) at 280 nm) and molecular weights were used: C1r, 12.4 and 86,300 (21); C1s, 14.5 and 79,800 (21, 11); C1 s ␥-B, 18.3 and 47,520 (22, 11) ; C2, 10.0 and 100,000 (18); C4, 8.2 and 205,000 (23, 24) ; C1 inhibitor, 3.86 and 105,000 (25) . The absorption coefficients (A (1%, 1 cm) at 280 nm) used for the recombinant fragments ap-SP (17.0) and CCP 2 -ap-SP (16.4) were calculated from their amino acid composition by the method of Edelhoch (26) , and their molecular weights were determined by mass spectrometry analysis (see "Results").
Construction of C1s Fragments CCP 2 -ap-SP and ap-SP-containing Expression Plasmids-
The following primers were obtained from Eurogentec (Seraing, Belgium) and used to amplify the desired human C1s cDNA sequences in a polymerase chain reaction using Vent R polymerase, according to established procedures: GAAGATCTTGACTGTGGC-ATTCCT (sense for CCP 2 -ap-SP); GGAATTCTTAGTCCTCACGGGG-GGT (antisense for CCP 2 -ap-SP and ap-SP); and GAAGATCTTCC-AGTCTGTGGAGTC (sense for ap-SP). The underlined sequences represent bases introduced either at the 5Ј end of the C1s cDNA to create a BglII site for in-frame cloning into the pNT-Bac expression vector or at the 3Ј end to create an EcoRI site. The pNT-Bac vector was constructed from the baculovirus expression vectors pVT-Bac (27) and pFast Bac1 TM (Life Technologies Inc.). Briefly, the segment comprised between the EcoRV and KpnI sites was excised from plasmid pVT-Bac and introduced between the SnaBI and KpnI sites in pFast Bac1. The resulting vector contains the polyhedrin promoter and the multiple cloning site region of pVT-Bac (Fig. 1) . It also encodes the melittin signal peptide previously used to enhance secretion of the papain precursor (27) and is therefore adapted to the production in a secreted form of fragments derived from the C-terminal end of proteins. The amplified DNAs were designated CCP 2 -ap-SP, encoding residues 343-673 in mature human C1s, and ap-SP, encoding residues 408 -673. These were purified and cloned into the pCR-Script Amp SK(ϩ) intermediate vector (Stratagene) according to the manufacturer's instruction. Both fragments were excised with BglII and EcoRI and introduced into the BamHI and EcoRI sites of the pNT-Bac vector by means of the T4 DNA ligase to create the plasmids pNT-Bac/CCP 2 -ap-SP and pNT-Bac/ap-SP. Clones containing the insert were identified by restriction enzyme analysis and checked for the absence of mutations introduced by polymerase chain reaction by double-stranded DNA sequencing using the T7 Sequencing TM kit (Pharmacia Biotech Inc.). Cells and Viruses-The insect cells, Spodoptera frugiperda (Sf21), were provided by Dr. Jadwiga Chroboczek (Institut de Biologie Structurale, Grenoble). The cells were maintained in TC100 medium (Life Technologies, Inc.) containing 5% fetal calf serum (JRH Biosciences) supplemented with 50 IU/ml penicillin and 50 mg/ml streptomycin (Sigma). Recombinant baculoviruses were generated by using the Bacto-Bac TM system (Life Technologies, Inc.) based on site-specific transposition of an expression cassette carried by the pNT-Bac-based recombinant plasmids into a baculovirus shuttle vector (bacmid) propagated in Escherichia coli (28) . Transposition of the pNT-Bac/CCP 2 -ap-SP and pNT-Bac/ap-SP plasmids into DH10Bac E. coli cells and selection of recombinant bacteria were performed as recommended by the manufacturer (Life Technologies, Inc.). The recombinant bacmids were purified using the Qiagen midiprep DNA purification system (Qiagen S.A., Courtaboeuf, France) and transfected into Sf21 cells with cellfectin in Sf900 II SFM medium (Life Technologies, Inc.) as recommended by the manufacturer. The transfection supernatant was decanted 4 days later, centrifuged, and stored at 4°C until use. The recombinant viruses, designated rCCP 2 -ap-SP and rap-SP, were titered by virus plaque assay and amplified as described by King and Possee (29) .
Protein Production and Purification-Sf21 cells (5 ϫ 10 5 cells/ml in spinner flasks or 2 ϫ 10 7 cells/175-cm 2 tissue culture flask) were infected with the recombinant viruses at a multiplicity of infection of 2-3 in Sf900 II SFM medium containing 50 IU/ml penicillin and 50 g/ml streptomycin. Tunicamycin (5 g/ml) was added for the production of the aglycosylated form of the CCP 2 -ap-SP fragment. After 96 h at 28°C, the supernatant was collected by centrifugation, and diisopropylphosphorofluoridate was added to a final concentration of 2 mM. The culture supernatant was dialyzed against 5 mM EDTA, 20 mM sodium phosphate, pH 8.6, and loaded at 2 ml/min onto a Mono Q HR 10/10 column (Pharmacia) equilibrated in the same buffer containing 1 mM diisopro- Further purification was achieved by high pressure hydrophobic interaction chromatography on a TSK-Phenyl 5PW column (Beckman) equilibrated in the same buffer containing 1 mM diisopropylphosphorofluoridate. Elution was carried out by decreasing the ammonium sulfate concentration from 1.5 M to 0 in 30 min at a flow rate of 1 ml/min. Both recombinant fragments were dialyzed against 50 mM triethanolamine HCl, 145 mM NaCl, pH 7.4, concentrated to 0.2-0.5 mg/ml by ultrafiltration on Microsep TM microconcentrators (molecular weight cut-off ϭ 10,000) (Filtron), and stored at Ϫ20°C.
Chemical Characterization of the Recombinant Proteins-N-terminal sequence analyses were performed either on soluble proteins or after SDS-PAGE analysis and electrotransfer, using an Applied Biosystems model 477A protein sequencer as described previously (12) . The matrixassisted laser desorption ionization (MALDI) technique was used for mass spectrometry analysis of the recombinant proteins, using a Voyager Elite XL instrument (PerSeptive Biosystems, Cambridge, MA), under conditions described previously (30) .
Functional Tests-Activation of proenzyme C1s and the recombinant fragments CCP 2 -ap-SP and ap-SP was tested by incubation of the proteins (6.5 M) in the presence of active C1 r (C1 r/protein molar ratio ϭ 0.045) for various periods at 37°C, in 50 mM triethanolamine HCl, 145 mM NaCl, pH 7.4. In the case of C1s and CCP 2 -ap-SP, activation was monitored by SDS-PAGE analysis under reducing conditions and subsequent quantification by gel scanning of the two-chain structure characteristic of the active state of the proteins (see Fig. 2 ). Activation of the smaller fragment ap-SP was measured by its ability to cleave the synthetic substrate N ␣ -benzoyl-L-arginine ethyl ester. The proteolytic activity of C1 s and its activated fragments ␥-B, CCP 2 -ap-SP, and ap-SP toward C2 and C4 was measured by incubation of the protein substrates in the presence of the enzymes for various periods at 37°C followed by SDS-PAGE analysis under reducing conditions and quantification by gel scanning of the fragments characteristic of the C1 s-mediated cleavage (respectively, C2a and C2b, and the C4␣Ј chain of the C4b fragment) (31, 32) . For determination of the kinetic parameters, the C2 and C4 concentrations ranged from 0.5 ϫ 10 Ϫ6 M to 4 ϫ 10 Ϫ6 M, with fixed enzyme concentrations of 2 ϫ 10 Ϫ9 M and 1.2 ϫ 10 Ϫ9 M, respectively. All experiments were conducted in 20 mM sodium phosphate, 150 mM NaCl, 5 mM EDTA, pH 7.4, whereas enzyme dilutions were performed in 50 mM triethanolamine HCl, 145 mM NaCl, pH 7.4, containing 1 mg/ml ovalbumin.
The esterolytic activity of C1 s and its various activated fragments was measured against N ␣ -benzoyl-L-arginine ethyl ester, using an alcohol dehydrogenase/NAD-coupled spectrophotometric test, as described previously (33) . The reactivity of the activated proteases toward C1 inhibitor was assessed by incubation in the presence of equimolar amounts of C1 inhibitor for 15 min at 37°C in 50 mM triethanolamine HCl, 145 mM NaCl, pH 7.4, followed by SDS-PAGE analysis under reducing conditions of the formation of the covalent C1 inhibitor-serine protease B chain complexes (20) .
Other Methods-SDS-PAGE analysis was performed as described previously (12) . Western blot analysis of the recombinant proteins after SDS-PAGE was performed by electrotransfer to a nitrocellulose membrane and blocking of unoccupied sites with 5% non-fat dry milk in 10 mM Tris-HCl, 200 mM NaCl, pH 7.2. The immobilized proteins were visualized by using a rabbit polyclonal anti-C1 s antiserum, followed by a goat anti-rabbit immunoglobulin fraction conjugated to alkaline phosphatase (Sigma) and staining according to the manufacturer's instructions.
RESULTS

Expression and Purification of Recombinant Proteins-
The modular structures of human C1s and of the various truncated fragments used in the present study are depicted in Fig. 2 . Construction of the recombinant baculoviruses, transposition of the pNT-Bac/CCP 2 -ap-SP and pNT-Bac/ap-SP plasmids into DH10Bac E. coli cells, and transfection of the corresponding recombinant bacmids into Sf21 cells were performed as described under "Experimental Procedures." The virus titer of the transfection supernatants after amplification was about 10 7 plaque forming units/ml in both cases. Infection of Sf21 cells by the supernatants was conducted for various periods at 28°C, and the amount of recombinant proteins secreted into the culture medium was monitored by SDS-PAGE and Western blot analysis. Under normal culture conditions, protein bands with the expected apparent molecular weights (see below) became detectable at 48 h, their intensity increasing progressively to reach a plateau at 96 h. In contrast, secretion of the CCP 2 -ap-SP fragment in the presence of tunicamycin reached a maximum at 72 h and decreased considerably after 96 h. Analysis of protein production in the cell pellets showed kinetic profiles similar to those observed for the supernatants. Under optimal production conditions, the amounts of recombinant protein secreted into the culture medium were estimated to be approximately 0.6 g/ml for ap-SP, 3 g/ml for CCP 2 -ap-SP, and 1.5 g/ml for the aglycosylated fragment CCP2-ap-SP (CCP 2 -apSPag) produced in the presence of tunicamycin.
The recombinant fragments were initially purified by fractionation of the culture supernatants by ion-exchange chromatography on a Mono Q column (Pharmacia). Both fragment CCP 2 -ap-SP and CCP 2 -ap-SPag yielded visible peaks at 280 nm eluting during the ascending salt gradient, slightly later than the C1 s ␥-B fragment produced by limited proteolysis. Fragment ap-SP, in contrast, was not retained on the column and eluted in the large flow-through fraction. Final purification was achieved by hydrophobic interaction chromatography. As illustrated in Fig. 3 , fragment CCP 2 -ap-SP eluted as a single peak at the end of the descending ammonium sulfate gradient, slightly later than the whole C1 s ␥-B fragment. Its aglycosylated form eluted essentially at the same position, whereas the shorter fragment ap-SP eluted at the middle of the gradient and was therefore significantly more hydrophilic. The amounts of purified proteins produced were typically about 0.4, 1.5, and 0.5 mg per liter of culture for fragments ap-SP, CCP 2 -ap-SP, and CCP 2 -ap-SPag, respectively.
The recombinant fragments were essentially pure as judged from SDS-PAGE analysis (Fig. 4) . Each yielded a single band under both non-reducing and reducing conditions, indicating that they were in the proenzyme form, with apparent molecular weights of about 30,000 (ap-SP), 40,000 (CCP 2 -ap-SP), and 38,000 (CCP 2 -ap-SPag), consistent with the predicted values. No sign of proteolytic degradation was observed on the gels upon storage of the recombinant proteins for several months at Ϫ20°C.
Chemical Characterization of Recombinant Proteins-Edman degradation of the purified fragments CCP 2 -ap-SP and (34) , and in keeping with our previous studies (11), the above values are consistent with the occurrence of short, heterogeneous oligosaccharides comprising two N-acetylglucosamine residues and a variable number of mannose residues ranging from 4 to 8 (calculated masses of the carbohydrate moiety ϭ 1,055 and 1,704, respectively). The significantly high differences between the experimental and calculated values likely arise from the fact that the former are average figures which do not necessarily correspond to a round number of mannose residues (see Fig. 5B ). In summary, N-terminal sequence and mass spectrometry analyses clearly showed that the recombinant proteins had the expected sequences and that a heterogeneous high mannose oligosaccharide was attached to Asn 391 of fragment CCP 2 -ap-SP.
Functional Characterization of Recombinant Proteins-As judged from SDS-PAGE analysis under reducing conditions, fragments CCP 2 -ap-SP, CCP 2 -ap-SPag, and ap-SP retained a monochain structure upon prolonged incubation at 37°C, indicating that the preparations were free of contaminating proteases. To test their activation by C1 r, i.e. their ability to be split at the Arg 422 -Ile 423 bond cleaved upon activation of intact C1s, each fragment was incubated for various periods at 37°C in the presence of C1 r. SDS-PAGE analysis under reducing conditions indicated that all three fragments were cleaved by C1 r: (i) in the case of CCP 2 -ap-SP and CCP 2 -ap-SPag, a twochain structure became clearly visible, as shown by the appearance of bands corresponding to the serine protease domain and to the CCP 2 -ap moieties; (ii) the apparent molecular weight of ap-SP was slightly decreased, suggesting removal of the short N-terminal activation peptide. Edman degradation of the C1 rtreated fragments gave evidence for a second sequence 423 IleIle-Gly-Gly-Ser-Asp-Ala . . . , in addition to the single N-terminal sequence yielded upon analysis of the monochain fragments (see above), confirming C1 r-mediated cleavage of the 422 ArgIle 423 bond in all cases. A comparative kinetic analysis of the activation of proenzyme C1s and the recombinant fragments CCP 2 -ap-SP and ap-SP by C1 r showed that all three proteins were activated in a comparable manner (Fig. 6) . It was concluded, therefore, that the structural determinants involved in the cleavage of proenzyme C1s by C1 r are contained solely in the C-terminal part of the protein, comprising the activation peptide and the serine protease domain.
The activated forms of the recombinant proteins CCP 2 -ap-SP and ap-SP were prepared by incubation with C1 r for 90 min at 37°C under the conditions described in the legend to Fig. 6 and tested for their enzymic activity as described below. Esterolytic activity was tested against N ␣ -benzoyl-L-arginine ethyl ester, which is not among the best synthetic substrates of C1 s, and was chosen because of its lack of cleavage by C1 r (33 To check whether the activated recombinant fragments also displayed proteolytic activity, their ability to cleave the C1 s protein substrates C2 and C4 was tested and compared with that of intact C1 s and its proteolytic ␥-B fragment. The two glycoforms of C1 s ␥-B, containing either a biantennary or a triantennary, complex-type oligosaccharide (11) were also tested. Kinetic analyses of C2 cleavage as a function of enzyme concentration clearly showed that all C1 s fragments had the ability to cleave C2 and yielded the C2a and C2b fragments characteristic of cleavage by intact C1 s (not shown). As summarized in Table I , the larger fragment ␥-B and both fragments CCP 2 -ap-SP (either glycosylated or aglycosylated) displayed kinetic constants very similar to those of intact C1 s. That the carbohydrate linked to the second CCP module had no significant influence on C2 cleavage was confirmed by the fact that the two glycoforms of C1 s ␥-B, as well as the desialylated protein, all exhibited comparable kinetic constants (not shown). The shorter fragment ap-SP also cleaved C2, although with a k cat value slightly less (about 50%) than those determined for the other fragments. Nevertheless, all of the fragments cleaved C2 efficiently, indicating that the first CCP module of C1 s and very likely also the second CCP module do not play a major role in C2 cleavage.
In the next step, we compared the ability of the various C1 s fragments to cleave C4. Kinetic analyses as a function of enzyme concentration were performed initially, indicating that the larger fragment ␥-B cleaved C4 to yield the expected C4␣Ј chain, with an efficiency comparable to that of intact C1 s (not shown). In contrast, as illustrated in Fig. 7 , a dramatic decrease in cleaving efficiency was observed for fragments CCP 2 -ap-SP and CCP 2 -ap-SPag, whereas C4-cleaving activity was abolished in the case of the shorter fragment ap-SP. No proteolytic activity toward C4 was detectable after incubation for 30 min at 37°C using ap-SP/C4 molar ratios up to 0.07 (not shown). Determination of the kinetic constants for C4 cleavage confirmed the above findings, indicating that C1 s and its ␥-B fragment had comparable k cat and K m values (Table II) . The two glycoforms and the asialylated form of C1 s ␥-B all exhibited similar catalytic constants (not shown). In the case of both fragments CCP 2 -ap-SP, in contrast, the k cat decreased about 15-20-fold, and the K m increased about 4-fold, leading to a mean decrease of the k cat /K m value of about 70, in agreement with the data shown in Fig. 7 . Thus, C4-cleaving activity was strongly reduced upon deletion of the N-terminal CCP module and abolished when both CCP modules were removed, indicating that both modules participate in C4 recognition by C1 s.
Finally, experiments aimed at checking the ability of the activated recombinant C1s fragments to react with the physiological protein inhibitor of C1 s, C1 inhibitor, were performed. After incubation with equimolar amounts of C1 inhibitor followed by SDS-PAGE analysis under reducing conditions (not shown), C1 s and all three fragments CCP 2 -ap-SP, CCP 2 -apSPag, and ap-SP yielded a band of apparent molecular weight Ͼ120,000, corresponding to the covalent complex formed between C1 inhibitor and the serine protease domain. In all cases, including C1 s, formation of the covalent complex was not complete under the conditions used, as shown by the presence of significant amounts of C1 inhibitor and the free form of the serine protease domain. However, the relative proportion of complex formed was comparable in all cases. As judged from these experiments, all fragments exhibited a reactivity toward C1 inhibitor comparable to that of intact C1 s, indicating that the C-terminal end of the protease, comprising the activation FIG. 6 . Kinetic analysis of the activation of C1s and the recombinant fragments CCP 2 -ap-SP and ap-SP by C1 r. Proenzyme C1s (q) and its recombinant fragments CCP 2 -ap-SP (E) and ap-SP (f) (each 6.5 M) were incubated with activated C1r (C1 r/protein molar ratio ϭ 0.045) for various periods at 37°C, in 50 mM triethanolamine HCl, 145 mM NaCl, pH 7.4. In the case of C1s and CCP 2 -ap-SP, activation was monitored by SDS-PAGE quantification of the two-chain structure characteristic of the active state of the proteins. Activation of fragment ap-SP was measured by esterolytic activity toward N ␣ -benzoyl-L-arginine ethyl ester (see "Experimental Procedures"). peptide and the serine protease domain, contains the structural determinants required for reaction with this inhibitor.
DISCUSSION
The baculovirus/insect cells expression system has been used successfully to produce a number of intact multidomain proteins, including human complement proteases C1r and C1s (35, 36) . In the present study, the recently developed Bac-to-Bac TM system (28) was used to express recombinant modular fragments from the catalytic region of human C1s. Although the secretion yields (0.6 -3.0 mg/liter cell culture) were low compared with some of those reported for intact proteins, they were sufficient to produce the purified fragments for chemical and functional characterization. In this respect, the significantly lower level of secretion of fragment ap-SP is probably related, at least in part, to a decreased stability and/or solubility compared with the larger fragment CCP 2 -ap-SP. Indeed, we have provided evidence that the second CCP module of C1 s is closely associated with the serine protease domain (12) . Removal of this module may therefore be expected to unmask hydrophobic areas of the serine protease domain and thereby to decrease its solubility. In contrast, the observed slight decrease in the secretion yield of the aglycosylated fragment CCP 2 -ap-SPag is probably not linked to a reduced stability of the protein in solution due to the lack of the oligosaccharide chain but rather is an indirect consequence of the deleterious effect of tunicamycin on insect cells, which is known to affect secretion of some proteins (37) . As shown by Edman degradation and mass spectrometry analyses, the recombinant C1s fragments produced in this study were homogeneous at the polypeptide level and had the expected N-terminal sequences and amino acid compositions. In contrast, the analyses performed on the glycosylated fragment CCP 2 -ap-SP are consistent with the occurrence at Asn 391 of heterogeneous high mannose type oligosaccharides containing a varying number of mannose residues ranging from 4 to 8, depending on the preparation, and even within a given preparation (see Fig. 5 ). Such a heterogeneity of the carbohydrate moiety of the glycoproteins expressed in baculovirus/insect cells systems could be a major disadvantage if these are produced for crystallographic purposes.
Several lines of evidence indicate that the carbohydrate borne by the second CCP module of C1 s is not significantly involved in the functional activities of this protease. Thus, the two glycoforms and the asialylated form of fragment C1 s ␥-B all display comparable proteolytic activities toward C2 and C4. Moreover, the aglycosylated form of fragment CCP 2 -ap-SP exhibits proteolytic kinetic constants similar to those of its glycosylated counterpart. It is very likely therefore that the two naturally occurring glycoforms of human C1 s display identical catalytic properties in vivo. The fact that complete removal of the carbohydrate from fragment CCP 2 -ap-SP does not impair its functional activity also suggests that this does not significantly affect the folding of the protein. Thus, despite the location of Asn 391 in the vicinity of the CCP module/serine protease domain interface (12) , the oligosaccharide chain itself is probably not directly involved in the interaction between the two domains. This observation lends further support to the abovementioned hypothesis that the decreased secretion of fragment CCP 2 -ap-SPag results from an indirect effect of tunicamycin on insect cells.
All of the recombinant fragments were produced and remained stable in a proenzyme form, indicating that, like the parent C1s molecule, none of them undergoes self-activation. In contrast, both fragments CCP 2 -ap-SP and ap-SP were readily activated in solution by C1 r, with an efficiency comparable to intact C1s. The shorter C1s fragment ap-SP therefore contains the structural information required for C1 r-mediated cleavage. Indeed, this appears consistent with the fact that C1s cleavage by C1 r normally does not occur in the fluid phase, but inside the C1 complex, in which the activation site of the former protease and the active site of the latter are expected to be pre-positioned with respect to each other (4) . It is likely, therefore, that C1s recognition by C1 r mainly involves a restricted number of residues on either side of the C1s Arg 422 -Ile 423 bond cleaved upon activation. In any case, it is clear that efficient cleavage does not require accessory binding sites outside the serine protease domain of C1s. It is noteworthy that C1 rmediated cleavage of fragments CCP 2 -ap-SP and ap-SP leads to the development of esterolytic activity in both cases, which again implies that the latter is self-sufficient for the formation of a fully active site, in agreement with current knowledge on active site formation in other serine proteases (38).
Our observation that the short C1 s fragment ap-SP retains the ability to form a stable complex with C1 inhibitor indicates that this contains the structural elements required for reaction with C1 inhibitor. It should be mentioned, however, that the reaction of C1 s with C1 inhibitor is a complex and still not fully understood process. Like other members of the serpin family, C1 inhibitor acts as a pseudosubstrate: C1 s cleaves C1 inhibitor at the Arg 444 -Thr 445 "reactive center," then the cleavage products do not dissociate, but a tight, SDS-stable enzymeinhibitor complex is formed (25) . It has been recently proposed FIG. 7 . Comparative analysis of C4 cleavage by increasing amounts of activated C1s and its recombinant fragments CCP 2 -ap-SP, CCP 2 -ap-SPag, and ap-SP. C4 (2.25 M) was incubated at 37°C in 20 mM sodium phosphate, 150 mM NaCl, 5 mM EDTA, pH 7.4, in the presence of increasing concentrations of C1 s (q) or the activated recombinant fragments CCP 2 -ap-SP (f), CCP 2 -ap-SPag (Ⅺ), and ap-SP (OE). The initial rate of C4 cleavage V 0 was measured by kinetic analysis by SDS-PAGE of the production of the C4␣Ј chain of fragment C4b (see "Experimental Procedures"). that formation of this stable complex involves a secondary interaction site on C1 inhibitor (39) . Obviously, a precise kinetic analysis of the reaction of C1 inhibitor with native C1 s and its ap-SP fragment would be necessary to check whether the latter behaves exactly as the parent protein at the different steps of the reaction. Nevertheless, our observation that C1 s and its fragment ap-SP yield comparable amounts of stable complexes with C1 inhibitor suggests that the proposed secondary interaction site on C1 inhibitor binds to the serine protease domain of C1 s. With regard to C2 cleaving activity, all C1 s fragments were found to cleave this substrate with an efficiency comparable with that of the intact protease. The fact that the shorter fragment ap-SP exhibits a slightly decreased k cat value can be rationalized by the following observations: (i) as discussed above, removal of the second CCP module may be expected to uncover hydrophobic patches of the serine protease domain and possibly to induce local denaturation resulting in partial loss of substrate binding site(s) at the surface of the domain; (ii) due to its lower solubility, the uncertainty on concentration measurements and hence on k cat was probably higher in the case of fragment ap-SP. Indeed, the observation that ap-SP exhibits a K m value for C2 comparable with that of the other fragments tends to favor the latter explanation. Therefore, our conclusion is that C2 recognition and cleavage by C1 s only involve structural motifs located within the ap-SP fragment and probably confined to the serine protease domain. In any case, our data provide no indication of a significant involvement of the remainder of the C1 s molecule, particularly the CCP modules.
In contrast, our data clearly show that, while fragment ␥-B exhibits a C4 cleaving activity comparable with that of intact C1 s, this activity is greatly reduced upon removal of the first CCP module and abolished when both CCP modules are deleted. Therefore, we conclude that both of these modules contribute accessory recognition sites for C4, which likely mediate binding and positioning of the substrate in such a way that the scissile bond fits into the C1 s active site, thereby allowing efficient cleavage of the protein. This hypothesis is consistent with the observation that fragment CCP 2 -ap-SP shows both an increased K m for C4 and a decreased k cat value (see Table II ). Thus, removal of the first CCP module would result in partial loss of the C4 binding site, resulting in improper positioning of the protein, and thereby in decreased cleavage efficiency. Our finding that both CCP modules of C1 s participate in C4 binding is in full agreement with previous studies (13, 14) indicating that monoclonal antibodies directed to the ␥ segment of the protease inhibit its ability to cleave C4. From a more general point of view, it should be emphasized that all complement regulatory proteins known to bind the C4b fragment of C4 (including complement receptor type 1 (CR1), membrane cofactor protein, decay accelerating factor, and C4b-binding protein) are composed mainly or entirely of CCP modules (10) . In the case of CR1, it has been shown by deletion experiments and site-directed mutagenesis that both the first and second CCP modules are required for C4b binding (40) . By analogy, the most likely hypothesis is therefore that the two CCP modules of C1 s bind to the C4b moiety of C4. This does not preclude, however, that other binding sites may be involved in the C1 s-C4 interaction. In this respect, it should be mentioned that plasmin degradation of the serine protease domain of C1 s was reported to result in the loss of C4 binding ability (14) . In the same way, it has been suggested that C1 s may interact with the C4a moiety of C4 through acidic residues close to the active site (41) . It may be hypothesized, therefore, that efficient positioning of C4 with respect to C1 s requires two types of interactions: (i) between the C4b moiety and the CCP modules and (ii) between the C4a moiety and the serine protease domain.
It is not surprising that C4 and C2 recognition by C1 s involves distinct structural requirements, since these protein substrates are quite different both in terms of size and modular organization. Also, it is well established that, in vivo, C4 cleavage occurs in the fluid phase, whereas C2 is cleaved within the C2-C4b complex that forms after covalent attachment of C4b in the vicinity of the C1 complex (5) . It may be expected, therefore, that appropriate "presentation" of C2 with respect to the C1 s active site is effected, at least in part, by C4b. In this respect, it is noteworthy that initial binding of C2 to C4b has recently been shown to involve the CCP modules of C2 (42) . Thus, the C4b moiety of native C4 would bind first to the CCP modules of C1 s, then the C4b fragment released upon C1 s cleavage would acquire preferential affinity for the homologous modules of C2.
The present study provides the first precise identification of the domains of C1 s involved in the various aspects of its catalytic activity, and this study also shows that its very restricted specificity and its ability to discriminate its two protein substrates arise for a large part from the occurrence of accessory substrate binding sites located outside the serine protease domain. Further studies are in progress to identify the residues of the CCP modules of C1 s that participate in C4 binding.
